Bleeding Patterns and Clinical Outcomes in Patients With Systemic <scp>AL</scp> Amyloidosis‐Related Acquired Factor X Deficiency
Okan Çetin(Istanbul University), Raphaël Szalat(Boston University), Vaishali Sanchorawala(Boston Medical Center), Patric Teodorescu(Boston University), Andrew Staron(Boston University), J. Mark Sloan(Boston University)
Cited by 1
Related Papers
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Systemic immunoglobulin light chain amyloidosis
|Nature Reviews Disease Primers|2018|550